These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 33595062)

  • 21. In-hospital complications after implantation of cardiac implantable electronic devices: Analysis of a national inpatient database in Japan.
    Shakya S; Matsui H; Fushimi K; Yasunaga H
    J Cardiol; 2017 Nov; 70(5):405-410. PubMed ID: 28434707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pocket haematoma after cardiac electronic device implantation in patients receiving antiplatelet and anticoagulant treatment: a single-centre experience.
    Demir GG; Guler GB; Guler E; Güneş H; Kizilirmak F; Karaca İO; Omaygenç MO; Çakal B; Olgun E; Savur U; Ibisoglu E; Barutçu I; Kiliçaslan F
    Acta Cardiol; 2017 Feb; 72(1):47-52. PubMed ID: 28597740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of COVID-19 pandemic on cardiac electronic device implantations in Northwestern Greece.
    Bechlioulis A; Sfairopoulos D; Korantzopoulos P
    Am J Cardiovasc Dis; 2021; 11(4):489-493. PubMed ID: 34548948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and organizational management of cardiac implantable electronic device replacements: an Italian Survey promoted by AIAC (Italian Association of Arrhythmology and Cardiac Pacing).
    Palmisano P; Ziacchi M; Belotti G; Rapacciuolo A; Santini L; Stabile G; Zoni Berisso M; De Ponti R; Landolina M; Ricci RP; Boriani G;
    J Cardiovasc Med (Hagerstown); 2019 Aug; 20(8):531-541. PubMed ID: 31259858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Redo procedures and chronic renal dysfunction are associated with higher risk of cardiac electronic device infections.
    Morani G; Mugnai G; Bolzan B; Morosato M; Tomasi L; Ferrari S; Vassanelli C
    Minerva Cardioangiol; 2018 Jun; 66(3):225-232. PubMed ID: 29308851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postmortem interrogation of cardiac implantable electrical devices may clarify time and cause of death.
    Riesinger L; Fichtner S; Schuhmann CG; Estner HL; Czermak T; Graw M; Fischer F; Lackermair K
    Int J Legal Med; 2019 May; 133(3):883-888. PubMed ID: 30238160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infections and associated costs following cardiovascular implantable electronic device implantations: a nationwide cohort study.
    Clémenty N; Carion PL; Léotoing L; Lamarsalle L; Wilquin-Bequet F; Brown B; Verhees KJP; Fernandes J; Deharo JC
    Europace; 2018 Dec; 20(12):1974-1980. PubMed ID: 29672690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A survey of cardiac implantable electronic device implantation in India: By Indian Society of Electrocardiology and Indian Heart Rhythm Society.
    Shenthar J; Bohra S; Jetley V; Vora A; Lokhandwala Y; Nabar A; Naik A; Calambur N; Gupta SB
    Indian Heart J; 2016; 68(1):68-71. PubMed ID: 26896270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety of same-day discharge versus overnight stay strategy following cardiac device implantations: a high-volume single-centre experience.
    Archontakis S; Oikonomou E; Sideris K; Laina A; Tirovola D; Paraskevopoulou D; Kostakis P; Doundoulakis I; Arsenos P; Ntalakouras I; Charitakis E; Gatzoulis K; Tsioufis K; Sideris S
    J Interv Card Electrophysiol; 2023 Mar; 66(2):471-481. PubMed ID: 36063282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variation in regional implantation patterns of cardiac implantable electronic device in Switzerland.
    Bolt L; Wertli MM; Haynes AG; Rodondi N; Chiolero A; Panczak R; Aujesky D
    PLoS One; 2022; 17(2):e0262959. PubMed ID: 35171922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peri-procedural routines, implantation techniques, and procedure-related complications in patients undergoing implantation of subcutaneous or transvenous automatic cardioverter-defibrillators: results of the European Snapshot Survey on S-ICD Implantation (ESSS-SICDI).
    Lenarczyk R; Boveda S; Haugaa KH; Potpara TS; Syska P; Jedrzejczyk-Patej E; Chauvin M; Sadoul N; Dagres N
    Europace; 2018 Jul; 20(7):1218-1224. PubMed ID: 29762683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular magnetic resonance imaging in patients with cardiac implantable electronic devices: best practice and real-world experience.
    Seewöster T; Löbe S; Hilbert S; Bollmann A; Sommer P; Lindemann F; Bacevičius J; Schöne K; Richter S; Döring M; Paetsch I; Hindricks G; Jahnke C
    Europace; 2019 Aug; 21(8):1220-1228. PubMed ID: 31131393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibacterial Envelope Is Associated With Low Infection Rates After Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Device Replacement: Results of the Citadel and Centurion Studies.
    Henrikson CA; Sohail MR; Acosta H; Johnson EE; Rosenthal L; Pachulski R; Dan D; Paladino W; Khairallah FS; Gleed K; Hanna I; Cheng A; Lexcen DR; Simons GR
    JACC Clin Electrophysiol; 2017 Oct; 3(10):1158-1167. PubMed ID: 29759500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The Pacemaker and Implantable Cardioverter-Defibrillator Registry of the Italian Association of Arrhythmology and Cardiac Pacing - Annual report 2015].
    Proclemer A; Zecchin M; D'Onofrio A; Boriani G; Botto GL; Facchin D; Rebellato L; Ghidina M; Bianco G; Bernardelli E; Pucher E; Gregori D
    G Ital Cardiol (Rome); 2017 Jan; 18(1):67-79. PubMed ID: 28287212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac implantable electronic devices in tracheotomized muscular dystrophy patients: Safety and risks.
    Fayssoil A; Lazarus A; Wahbi K; Ogna A; Nardi O; Lofaso F; Clair B; Orlikowski D; Annane D
    Int J Cardiol; 2016 Nov; 222():975-977. PubMed ID: 27526372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The Pacemaker and Implantable Cardioverter-Defibrillator Registry of the Italian Association of Arrhythmology and Cardiac Pacing - Annual report 2018].
    Proclemer A; Zecchin M; D'Onofrio A; Boriani G; Ricci RP; Rebellato L; Ghidina M; Bianco G; Bernardelli E; Miconi A; Zorzin AF; Gregori D
    G Ital Cardiol (Rome); 2020 Feb; 21(2):157-169. PubMed ID: 32051640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of changing antiseptic skin preparation agent used for cardiac implantable electronic device (CIED) procedures on the risk of infection.
    Qintar M; Zardkoohi O; Hammadah M; Hsu A; Wazni O; Wilkoff BL; Tarakji KG
    Pacing Clin Electrophysiol; 2015 Feb; 38(2):240-6. PubMed ID: 25224666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The Pacemaker and Implantable Cardioverter-Defibrillator Registry of the Italian Association of Arrhythmology and Cardiac Pacing - Annual report 2017].
    Proclemer A; Zecchin M; D'Onofrio A; Ricci RP; Boriani G; Rebellato L; Ghidina M; Bianco G; Bernardelli E; Miconi A; Zorzin AF; Gregori D
    G Ital Cardiol (Rome); 2019 Mar; 20(3):136-148. PubMed ID: 30821295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The Pacemaker and Implantable Cardioverter-Defibrillator Registry of the Italian Association of Arrhythmology and Cardiac Pacing - Annual report 2016].
    Proclemer A; Zecchin M; D'Onofrio A; Boriani G; Facchin D; Rebellato L; Ghidina M; Bianco G; Bernardelli E; Pucher E; Gregori D
    G Ital Cardiol (Rome); 2018 Feb; 19(2):119-131. PubMed ID: 29531385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Avoiding implant complications in cardiac implantable electronic devices: what works?
    Frausing MHJP; Kronborg MB; Johansen JB; Nielsen JC
    Europace; 2021 Feb; 23(2):163-173. PubMed ID: 33063088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.